Alzheimer Disease

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease [Series]

Supported by educational grants from ACADIA Pharmaceuticals Inc.; Allergan; Avanir Pharmaceuticals, Inc.; and Biogen MA, Inc.

	Webcast | Credits: 1.00 | Expires 8/31/2021 Addressing Challenges in Alzheimer's Disease Atri et al In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer’s disease.

	JCP CME | Credits: 1.00 | Expires 12/31/2021 Patient-Centered Care for Alzheimer's Disease Atri et al Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer’s disease that ensure safety, optimize patient autonomy, and minimize agitation and conflict.

	Brief Report | Credits: 1.50 | Expires 6/30/2021 Cognitive Assessment for Alzheimer’s Disease Shaughnessy et al Meaningful benefits can be derived from the evaluation of cognition in older adults when there is possible cognitive impairment and dementia. In this CME activity, experts explain how brief cognitive assessment tools and neuropsychological evaluations can aid diagnosis and inform a management plan.

	Brief Report | Credits: 1.00 | Expires 2/28/2021 Disclosure of Dementia Diagnosis Goldfarb et al Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. But doing so in a timely fashion benefits patients and their care partners. In this CME activity, learn about using patient-centered communication and following a structured process to disclose the diagnosis.

	Did you know?
	Two analogs of tetrabenazine are recommended as treatment for tardive dyskinesia in the updated American Academy of Neurology guidelines and are FDA-approved for this indication.
Find out more